A post hoc analysis of the BEATcc trial showed that atezolizumab plus chemotherapy and bevacizumab provided clinical benefit ...

Canada can build successful diabetes prevention and remission programs across the country by learning from England and ...

Dr Ursula A. Matulonis comments on how endometrial cancer treatment is rapidly evolving with new immunotherapies and targeted ...

A single dose of a synthetic form of psilocybin is safe and clinically meaningful in reducing treatment-resistant depression, ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...

Clinicians caution that while the app flags possible anemia, definitive diagnosis requires lab testing, patient history and ...

The number of students choosing family medicine residencies won’t keep up with the demand going forward. Potential solutions ...

Dementia rates are higher in the Southeast and Northwest US regions compared to the Mid-Atlantic region, a new study shows.

I'm your host, Kaniksha Desai. Today we're exploring the expanding role of molecular marker testing in the evaluation of thyroid nodules, particularly those patients with indeterminate cytology.

Acute dacryocystitis is common in women, and the risk for the condition rises with age, especially in those with primary acquired nasolacrimal duct obstruction.

A meta-analysis of randomized trials of ivermectin suggests protection against COVID-19, but could there be problems with the study? Dr F. Perry Wilson digs in.

Save the USPSTF The USPSTF is facing threats from a Supreme Court case, cuts to HHS programs, and the planned elimination of AHRQ. Dr Kenny Lin says now is the time for primary care physicians to ...